TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $66,000 | -64.9% | 94,401 | 0.0% | 0.00% | -66.7% |
| Q2 2016 | $188,000 | -17.5% | 94,401 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $228,000 | -68.5% | 94,401 | 0.0% | 0.00% | -69.2% |
| Q4 2015 | $724,000 | +45.1% | 94,401 | 0.0% | 0.01% | +30.0% |
| Q3 2015 | $499,000 | -13.7% | 94,401 | +46.6% | 0.01% | -9.1% |
| Q2 2015 | $578,000 | – | 64,401 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|